- Home
- ORGN vs NVCT Comparison
ORGN vs NVCT Comparison
Compare ORGN & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGN | NVCT |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.4M | 197.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ORGN | NVCT |
|---|---|---|
| Price | $0.28 | $7.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | ★ 1.4M | 91.6K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $25,122,000.00 | N/A |
| Revenue This Year | $49.18 | N/A |
| Revenue Next Year | $144.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.28 | $4.44 |
| 52 Week High | $1.36 | $11.52 |
Technical Indicators
Market Signals| Indicator | ORGN | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 20.87 | 71.56 |
| Support Level | $0.43 | $6.47 |
| Resistance Level | $0.46 | $7.77 |
| Average True Range (ATR) | 0.04 | 0.40 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 4.71 | 92.07 |
Price Performance
Historical ComparisonAbout ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.